Other Clinical Trial - AXONE-Acute II: Acute Assessment of a Micro

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04376983` - Effect of Implant-based Telerehabilitation	N/A
Recruiting	`NCT02814942` - Prospective Evaluation of Asians With CRT for Heart Failure
Completed	`NCT03750058` - Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy	N/A
Recruiting	`NCT00472238` - Effects of Endurance Training on Patients With Reduced Left Ventricular Ejection Fraction (LVEF) and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT04376983 - Effect of Implant-based Telerehabilitation

N/A

Recruiting

NCT02814942 - Prospective Evaluation of Asians With CRT for Heart Failure

Completed

NCT03750058 - Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy

N/A

Recruiting

NCT00472238 - Effects of Endurance Training on Patients With Reduced Left Ventricular Ejection Fraction (LVEF) and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04156412
Study type	Interventional
Source	University Hospital, Rouen
Contact	Frédéric ANSELME, Pr
Phone	+3323288
Email	frederic.anselme@chu-rouen.fr
Status	Recruiting
Phase	N/A
Start date	January 2, 2020
Completion date	October 2020

AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy — AXONE-Acute-2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms